[1]姜小娥.中西医结合治疗慢性乙肝的临床观察[J].医学信息,2019,32(10):160-162.[doi:10.3969/j.issn.1006-1959.2019.10.053]
　JIANG Xiao-e.Clinical Observation on Treatment of Chronic Hepatitis B with Integrative Medicine Therapy[J].Journal of Medical Information,2019,32(10):160-162.[doi:10.3969/j.issn.1006-1959.2019.10.053]
点击复制

中西医结合治疗慢性乙肝的临床观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年10期
页码:
160-162
栏目:
中医中药
出版日期:
2019-05-15

文章信息/Info

Title:
Clinical Observation on Treatment of Chronic Hepatitis B with Integrative Medicine Therapy
文章编号:
1006-1959（2019）10-0160-03
作者:
姜小娥
（鄱阳县人民医院感染科，江西 鄱阳 333100）
Author(s):
JIANG Xiao-e
(Department of Infectious Disease,Poyang County People's Hospital,Poyang 333100,Jingxi,China)
关键词:
慢性乙肝; 中西医结合; 疏肝健脾
Keywords:
Chronic hepatitis B; Combination of traditional Chinese and western medicine; Soothing liver and invigorating spleen
分类号:
R512.6+2
DOI:
10.3969/j.issn.1006-1959.2019.10.053
文献标志码:
A
摘要:
目的 探究应用中西医结合疗法对慢性乙肝患者进行治疗的临床效果。方法 选取2016年10月~2017年11月于我院进行诊治的慢性乙肝患者86例，随机分为常规组与观察组，每组43例。常规组患者采用拉米夫定和肌苷片进行治疗；观察组患者在常规组的治疗基础上添加自拟疏肝健脾方剂进行治疗。对比两组患者治疗后的谷丙转氨酶（ALT）、谷草转氨酶（AST）、总胆红素（TBIL）等肝功能指数及治疗效果。结果 观察组TP为（67.62±3.17）g/L，高于常规组的（61.57±3.29）g/L，观察组AST（47.88±18.97）U/L、ALT（61.29±27.77）U/L和TBIL（27.33±9.28）μmol/L分别低于常规组的（47.88±18.97）U/L、（53.57±26.64）U/L、（38.59±9.77）μmol/L，差异均有统计学意义（P＜0.05）。观察组治疗的总有效率为86.05%，高于常规组的65.12%，差异有统计学意义（P＜0.05）。结论 中西医结合治疗慢性乙肝疗效显著，可有效促进患者肝功能的恢复，提高疗效，值得临床借鉴。
Abstract:
Objective To explore the clinical effect of the treatment of chronic hepatitis B patients with integrative medicine therapy.Methods 86 patients with chronic hepatitis B who were treated in our hospital from October 2016 to November 2017 were randomly divided into the conventional group and the observation group, with 43 cases in each group. The patients in the conventional group were treated with lamivudine and inosine tablets; the patients in the observation group were treated with the traditional Shugan Jianpi Recipe on the basis of the treatment of the conventional group.The liver function indexes and therapeutic effects of alanine aminotransferase (ALT), aspartate aminotransferase(AST),and total bilirubin (TBIL) were compared between the two groups.Results The TP of the observation group was (67.62±3.17) g/L, which was higher than that of the conventional group (61.57±3.29) g/L, and the observed group AST (47.88±18.97) U/L, ALT (61.29±27.77) U/L and TBIL (27.33±9.28) μmol/L was lower than that of the conventional group (47.88±18.97 U/L,(53.57±26.64) U/L,(38.59±9.77) μmol/L, the difference was statistically significant (P<0.05). The total effective rate of the observation group was 86.05%, which was higher than that of the conventional group 65.12%,the difference was statistically significant (P<0.05).Conclusion The combination of traditional Chinese medicine and western medicine has significant curative effect on chronic hepatitis B, which can effectively promote the recovery of liver function and improve the curative effect. It is worthy of clinical reference.

参考文献/References:

[1]李晓华.中西医结合治疗慢性乙型肝炎肝纤维化及早期肝硬化的效果研究[J].中医临床研究,2015,7(33):87-88.
[2]王军英,薛连彬.中西医结合治疗慢性乙型肝炎疗效观察[J].陕西中医,2015,36(7):845-846.
[3]Chang KC,Wu JF,Hsu HY,et al.Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection[J].Pediatrics&Neonatology,2015,57(5):390-395.
[4]侯著丰,余世敏,胡东辉.评价中西医结合疗法对慢性乙型肝炎ALT、HBeAg和HBV-DNA的影响[J].现代预防医学,2015,42(8):1535-1537.
[5]兰菊.中西医结合治疗慢性乙肝临床研究进展[J].现代中西医结合杂志,2017,26(7):794-796.
[6]姜一鸣,姜学连,刘新军,等.中医综合治疗慢性乙型肝炎肝纤维化优化方案的研究[J].世界中西医结合杂志,2015,10(1):75-77.
[7]Lim YS,Han S,Heo NY,et al.Mortality,Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine[J]. Gastroenterology,2014,147(1):152-161.
[8]吴永斌,王修锋.中西医结合治疗慢性乙型肝炎肝纤维化120例临床研究[J].江苏中医药,2016,48(8):27-29.
[9]冯培民,陈谦,陈蕾,等.恩替卡韦结合中药治疗慢性乙型肝炎疗效的Meta分析[J].现代预防医学,2015,42(1):180-183.

相似文献/References:

[1]张君红,李洪梅,井 洁,等.溃疡性结肠炎中西医结合治疗研究[J].医学信息,2018,31(09):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
　ZHANG Jun-hong,LI Hong-mei,JING Jie,et al.Study on the Treatment of Ulcerative Colitis with Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2018,31(10):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
[2]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(10):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[3]罗 晨,杨嘉恩,梁惠卿.酒精性肝病中西医辨治研究进展[J].医学信息,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]
　LUO Chen,YANG JIA-en,LIANG HUI-qin.Advances in Differentiation and Treatment of Traditional Chinese and Western Medicine for Alcoholic Hepatitis[J].Journal of Medical Information,2018,31(10):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]
[4]陈雪梅,肖 瑶.广州地区西医现代期刊文献研究[J].医学信息,2019,32(03):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
　CHEN Xue-mei,XIAO Yao.Research on Western Modern Periodicals of Medicine Literature in Guangzhou Area[J].Journal of Medical Information,2019,32(10):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
[5]刘 浩,黄 娟.中西医结合临床专业外科基本技术培训模式改革研究[J].医学信息,2019,32(03):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
　LIU Hao,HUANG Juan.Research on the Reform of Basic Technical Training Mode of Clinical Specialty in Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2019,32(10):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
[6]李 英,欧宁江,孔俊绯.中西医结合治疗变应性结膜炎的临床观察[J].医学信息,2018,31(19):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
　LI Ying,OU Ning-jiang,KONG Jun-fei.Clinical Observation on Treatment of Allergic Conjunctivitis with Combination of Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2018,31(10):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
[7]裴金娜,刘 静,梁震峰,等.中西医结合治疗急性前壁ST段抬高型心肌梗死的临床疗效[J].医学信息,2019,32(08):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
　PEI Jin-na,LIU Jing,LIANG Zhen-feng,et al.Clinical Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Acute Anterior Wall ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(10):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
[8]阮兴秋,莫 鹏.五海瘿瘤丸联合微波消融术治疗乳房良性肿瘤临床研究[J].医学信息,2019,32(11):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
　RUAN Xing-qiu,MO Peng.Clinical Study on Treatment of Benign Breast Tumors with Wuhai Yingliu Pills Combined with Microwave Ablation[J].Journal of Medical Information,2019,32(10):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
[9]邓 伟.冠脉无复流的危险因素及治疗[J].医学信息,2021,34(03):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
　DENG Wei.Risk Factors and Treatment of No-reflow of Coronary Artery[J].Journal of Medical Information,2021,34(10):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
[10]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2019,32(10):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]

更新日期/Last Update: 2019-05-15